Access the full text.
Sign up today, get DeepDyve free for 14 days.
R. Hoh, Shilpa Joshi, Ji-Yeun Lee, B. Martin, S. Varma, Shirley Kwok, S. Nielsen, P. Nejad, Emily Haraguchi, P. Dixit, S. Shutthanandan, K. Roskin, Wenming Zhang, Dana Tupa, B. Bunning, M. Manohar, R. Tibshirani, N. Fernandez-Becker, N. Kambham, R. West, R. Hamilton, M. Tsai, S. Galli, R. Chinthrajah, K. Nadeau, S. Boyd (2020)
Origins and clonal convergence of gastrointestinal IgE+ B cells in human peanut allergyScience Immunology, 5
M. Gorelik, S. Narisety, A. Guerrerio, K. Chichester, C. Keet, A. Bieneman, R. Hamilton, R. Wood, J. Schroeder, P. Frischmeyer-Guerrerio (2015)
Suppression of the immunologic response to peanut during immunotherapy is often transient.The Journal of allergy and clinical immunology, 135 5
L. Mondoulet, V. Dioszeghy, F. Busato, Camille Plaquet, Véronique Dhelft, K. Bethune, Laurence Leclere, C. Daviaud, Mélanie Ligouis, Hugh Sampson, Hugh Sampson, Christophe Dupont, Jörg Tost (2018)
Gata3 hypermethylation and Foxp3 hypomethylation are associated with sustained protection and bystander effect following epicutaneous immunotherapy in peanut‐sensitized miceAllergy, 74
H. Brough, A. Liu, S. Sicherer, Kerry Makinson, A. Douiri, S. Brown, A. Stephens, W. McLean, V. Turcanu, R. Wood, S. Jones, W. Burks, P. Dawson, D. Stablein, H. Sampson, G. Lack (2015)
Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergyThe Journal of Allergy and Clinical Immunology, 135
J. Orengo, Allen Radin, V. Kamat, A. Badithe, Li-Hong Ben, Brandy Bennett, S. Zhong, D. Birchard, Andre Limnander, A. Rafique, Joannie Bautista, Aleksandar Kostić, D. Newell, Xunbao Duan, Matthew Franklin, William Olson, Tammy Huang, N. Gandhi, A. LipsichLeah, N. Stahl, N. Papadopoulos, Andrew Murphy, G. Yancopoulos (2018)
Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagementNature Communications, 9
(2015)
DBV Technologies Receives FDA Breakthrough Therapy Designation for Viaskin Peanut for the Treatment of Peanut Allergy in Children
M. Rivas, O. Burton, Petra Wise, L. Charbonnier, Peter Georgiev, H. Oettgen, R. Rachid, T. Chatila (2015)
Regulatory T cell reprogramming toward a Th2-cell-like lineage impairs oral tolerance and promotes food allergy.Immunity, 42 3
T. Muto, A. Fukuoka, K. Kabashima, S. Ziegler, K. Nakanishi, Kazufumi Matsushita, T. Yoshimoto (2014)
The role of basophils and proallergic cytokines, TSLP and IL-33, in cutaneously sensitized food allergy.International immunology, 26 10
E. Wambre, V. Bajzik, J. DeLong, Kimberly O’Brien, Quynh-Anh Nguyen, C. Speake, V. Gersuk, H. DeBerg, E. Whalen, Chester Ni, M. Farrington, D. Jeong, D. Robinson, P. Linsley, B. Vickery, W. Kwok (2017)
A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disordersScience Translational Medicine, 9
Jian Tan, Craig McKenzie, P. Vuillermin, G. Goverse, C. Vinuesa, R. Mebius, L. Macia, C. Mackay (2016)
Dietary Fiber and Bacterial SCFA Enhance Oral Tolerance and Protect against Food Allergy through Diverse Cellular Pathways.Cell reports, 15 12
M. Castro, J. Corren, I. Pavord, J. Maspero, S. Wenzel, K. Rabe, W. Busse, L. Ford, L. Sher, M. Fitzgerald, C. Katelaris, Y. Tohda, Bingzhi Zhang, H. Staudinger, G. Pirozzi, N. Amin, M. Ruddy, B. Akinlade, A. Khan, J. Chao, R. Martinčová, N. Graham, J. Hamilton, B. Swanson, N. Stahl, G. Yancopoulos, A. Teper (2018)
Dupilumab Efficacy and Safety in Moderate‐to‐Severe Uncontrolled AsthmaThe New England Journal of Medicine, 378
J. Regan, Yun Cao, M. Dispenza, Shuo Ma, L. Gordon, A. Petrich, B. Bochner (2017)
Ibrutinib, a Bruton's tyrosine kinase inhibitor used for treatment of lymphoproliferative disorders, eliminates both aeroallergen skin test and basophil activation test reactivity.The Journal of allergy and clinical immunology, 140 3
M. Khodoun, S. Tomar, J. Tocker, Yui-Hsi Wang, F. Finkelman (2018)
Prevention of food allergy development and suppression of established food allergy by neutralization of thymic stromal lymphopoietin, IL‐25, and IL‐33The Journal of Allergy and Clinical Immunology, 141
M. Dispenza, J. Pongracic, A. Singh, B. Bochner (2018)
Short‐term ibrutinib therapy suppresses skin test responses and eliminates IgE‐mediated basophil activation in adults with peanut or tree nut allergyThe Journal of Allergy and Clinical Immunology, 141
(2018)
Anti- IgE treatment with oral immunotherapy in multifood allergic participants: a doubleblind, randomised, controlled trial. Lancet Gastroenterol Hepatol
Sandra Andorf, M. Manohar, T. Dominguez, W. Block, Dana Tupa, Rohun Kshirsagar, V. Sampath, R. Chinthrajah, K. Nadeau (2017)
Observational long-term follow-up study of rapid food oral immunotherapy with omalizumabAllergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology, 13
Lifelong memory responses perpetuate humoral T H 2 immunity and anaphylaxis in patients with food allergy
Jessica Savage, K. Lee-Sarwar, J. Sordillo, S. Bunyavanich, Yanjiao Zhou, G. O'Connor, M. Sandel, L. Bacharier, R. Zeiger, E. Sodergren, G. Weinstock, D. Gold, S. Weiss, A. Litonjua (2018)
A prospective microbiome‐wide association study of food sensitization and food allergy in early childhoodAllergy, 73
G. Gauvreau, L. Boulet, D. Cockcroft, J. FitzGerald, I. Mayers, C. Carlsten, M. Laviolette, K. Killian, B. Davis, M. Larché, C. Kipling, B. Dua, Sofia Mosesova, W. Putnam, Yanan Zheng, H. Scheerens, Dana McClintock, J. Matthews, P. O'Byrne (2013)
OX40L blockade and allergen-induced airway responses in subjects with mild asthmaClinical and Experimental Allergy, 44
Oliver Burton, Oliver Burton, J. Tamayo, J. Tamayo, Amanda Stranks, Samuel Miller, K. Koleoglou, E. Weinberg, Hans Oettgen, Hans Oettgen (2018)
IgE promotes type 2 innate lymphoid cells in murine food allergyClinical & Experimental Allergy, 48
U. Gowthaman, Jennifer Chen, Biyan Zhang, William Flynn, Yisi Lu, Wenzhi Song, Julie Joseph, Jake Gertie, Lan Xu, Magalie Collet, J. Grassmann, T. Simoneau, David Chiang, M. Berin, Joseph Craft, Jason Weinstein, Adam Williams, S. Eisenbarth (2019)
Identification of a T follicular helper cell subset that drives anaphylactic IgEScience, 365
J. Leyva-Castillo, C. Galand, C. Kam, O. Burton, Michael Gurish, Melissa Musser, Jeffrey Goldsmith, E. Hait, S. Nurko, F. Brombacher, C. Dong, F. Finkelman, Richard Lee, S. Ziegler, I. Chiu, K. Austen, R. Geha (2019)
Mechanical Skin Injury Promotes Food Anaphylaxis by Driving Intestinal Mast Cell Expansion.Immunity, 50 5
S. Bunyavanich, N. Shen, Alexander Grishin, R. Wood, W. Burks, P. Dawson, S. Jones, D. Leung, H. Sampson, S. Sicherer, J. Clemente (2016)
Early-life gut microbiome composition and milk allergy resolution.The Journal of allergy and clinical immunology, 138 4
(2020)
Phase 2 Randomized Controlled Trial Using Biologics to Improve Multi OIT Outcomes
Technologies DBV, Double-Blind A. Placebo-Controlled Randomized Trial to Study the Viaskin Milk Efficacy and Safety for Treating IgE-Mediated Cow's Milk Allergy in Children. clinicaltrials. gov
Taylor Feehley, C. Plunkett, R. Bao, Sung Hong, Elliot Culleen, P. Belda-Ferre, Evelyn Campbell, R. Aitoro, R. Nocerino, L. Paparo, J. Andrade, D. Antonopoulos, R. Canani, C. Nagler (2018)
Healthy infants harbor intestinal bacteria that protect against food allergyNature medicine, 25
Kelly Orgel, C. Burk, Johanna Smeekens, J. Suber, Lakeya Hardy, R. Guo, A. Burks, M. Kulis (2018)
Blocking antibodies induced by peanut oral and sublingual immunotherapy suppress basophil activation and are associated with sustained unresponsivenessClinical & Experimental Allergy, 49
S. Jones, S. Sicherer, A. Burks, D. Leung, R. Lindblad, P. Dawson, A. Henning, M. Berin, David Chiang, B. Vickery, R. Pesek, C. Cho, F. Davidson, M. Plaut, H. Sampson, R. Wood
Food , drug , insect sting allergy , and anaphylaxis Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults
Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis -Full Text View -ClinicalTrials.gov
M. Rivas, O. Burton, Petra Wise, Yu-qian Zhang, S. Hobson, M. Lloret, C. Chehoud, Justin Kuczynski, T. DeSantis, J. Warrington, Embriette Hyde, J. Petrosino, G. Gerber, L. Bry, H. Oettgen, S. Mazmanian, T. Chatila (2013)
A microbiota signature associated with experimental food allergy promotes allergic sensitization and anaphylaxis.The Journal of allergy and clinical immunology, 131 1
Liane Mozère (2017)
In Early Childhood
C. Bachert, C. Bachert, L. Mannent, R. Naclerio, J. Mullol, B. Ferguson, P. Gevaert, P. Hellings, L. Jiao, Ling Wang, R. Evans, G. Pirozzi, N. Graham, B. Swanson, J. Hamilton, A. Radin, N. Gandhi, N. Stahl, G. Yancopoulos, E. Sutherland (2016)
Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial.JAMA, 315 5
J. Brandström, M. Vetander, Gunnar Lilja, S. Johansson, A. Sundqvist, Frida Kalm, Frida Kalm, Caroline Nilsson, A. Nopp (2017)
Individually dosed omalizumab: an effective treatment for severe peanut allergyClinical & Experimental Allergy, 47
K. Yamaki, S. Yoshino (2016)
A new, rapid in vivo method to evaluate allergic responses through distinctive distribution of a fluorescent-labeled immune complex: Potential to investigate anti-allergic effects of compounds administered either systemically or topically to the skin.Journal of immunological methods, 428
Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic Dermatitis. clinicaltrials. gov; 2020
M. Dispenza, Rebecca Krier-Burris, K. Chhiba, B. Undem, Piper Robida, B. Bochner (2020)
Bruton's tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxis.The Journal of clinical investigation
Jessica Savage, J. Courneya, P. Sterba, D. MacGlashan, S. Saini, R. Wood (2012)
Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy.The Journal of allergy and clinical immunology, 130 5
(2020)
Peanut allergen powder (Palforzia).The Medical letter on drugs and therapeutics, 62 1593
D. Leung, A. Calatroni, L. Zaramela, P. LeBeau, Nathan Dyjack, K. Brar, G. David, Keli Johnson, S. Leung, M. Ramirez-Gama, Bo Liang, C. Rios, M. Montgomery, Brittany Richers, C. Hall, Kathryn Norquest, John Jung, I. Bronova, Simion Kreimer, C. Talbot, D. Crumrine, R. Cole, P. Elias, K. Zengler, M. Seibold, E. Berdyshev, E. Goleva (2019)
The nonlesional skin surface distinguishes atopic dermatitis with food allergy as a unique endotypeScience Translational Medicine, 11
A. Blázquez, M. Berin (2008)
Gastrointestinal Dendritic Cells Promote Th2 Skewing via OX40L1The Journal of Immunology, 180
J. Arm, I. Bottoli, A. Skerjanec, D. Floch, A. Groenewegen, S. Maahs, C. Owen, I. Jones, P. Lowe (2014)
Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjectsClinical and Experimental Allergy, 44
S. Asrat, Navneet Kaur, Xia Liu, L. Ben, Daisuke Kajimura, A. Murphy, M. Sleeman, Andre Limnander, J. Orengo (2020)
Chronic allergen exposure drives accumulation of long-lived IgE plasma cells in the bone marrow, giving rise to serological memoryScience Immunology, 5
O. Burton, J. Tamayo, Amanda Stranks, K. Koleoglou, H. Oettgen (2018)
Allergen‐specific IgG antibody signaling through Fc&ggr;RIIb promotes food toleranceThe Journal of Allergy and Clinical Immunology, 141
B. Ruiter, Neal Smith, Brinda Monian, A. Tu, Elizabeth Fleming, Yamini Virkud, S. Patil, C. Whittaker, J. Love, W. Shreffler (2020)
Expansion of the CD4+ effector T cell repertoire characterizes peanut-allergic patients with heightened clinical sensitivity.The Journal of allergy and clinical immunology
M. Rivas, O. Burton, H. Oettgen, T. Chatila (2016)
IL-4 production by group 2 innate lymphoid cells promotes food allergy by blocking regulatory T-cell function.The Journal of allergy and clinical immunology, 138 3
R. Chinthrajah, N. Purington, Sandra Andorf, Andrew Long, K. O’Laughlin, S. Lyu, M. Manohar, Scott Boyd, R. Tibshirani, H. Maecker, M. Plaut, K. Mukai, M. Tsai, M. Desai, Stephen Galli, Kari Nadeau (2019)
Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 studyThe Lancet, 394
H. Sampson, Donald Leung, A. Burks, G. Lack, S. Bahna, S. Jones, Dennis Wong (2011)
A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy.The Journal of allergy and clinical immunology, 127 5
David Chiang, Xintong Chen, S. Jones, R. Wood, S. Sicherer, Wesley Burks, D. Leung, Charuta Agashe, Alexander Grishin, P. Dawson, W. Davidson, Leah Newman, R. Sebra, M. Merad, H. Sampson, B. Losic, C. Berin (2018)
Single‐cell profiling of peanut‐responsive T cells in patients with peanut allergy reveals heterogeneous effector TH2 subsetsThe Journal of Allergy and Clinical Immunology, 141
A Phase I Open Label Trial to Evaluate the Safety and Efficacy of Oral Encapsulated Fecal Microbiota Transplantation in Peanut Allergic Patients. Clinicaltrials.gov; 2020
M. Mäkelä (2020)
Review for "Pathogenesis of IgE‐mediated food allergy and implications for future immunotherapeutics"Applied Immunohistochemistry & Molecular Morphology
R. Canani, M. Costanzo, G. Bedogni, Antonio Amoroso, L. Cosenza, C. Scala, V. Granata, R. Nocerino (2017)
Extensively hydrolyzed casein formula containing Lactobacillus rhamnosus GG reduces the occurrence of other allergic manifestations in children with cow's milk allergy: 3‐year randomized controlled trialThe Journal of Allergy and Clinical Immunology, 139
A. Fiocchi, M. Artesani, C. Riccardi, M. Mennini, V. Pecora, V. Fierro, Veronica Calandrelli, L. Dahdah, R. Valluzzi (2019)
Impact of Omalizumab on Food Allergy in Patients Treated for Asthma: A Real-Life Study.The journal of allergy and clinical immunology. In practice
Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy -Full Text View -ClinicalTrials.gov
Mina Fazlollahi, Yoojin Chun, Alexander Grishin, Robert Wood, A. Burks, Peter Dawson, S. Jones, Donald Leung, H. Sampson, S. Sicherer, S. Bunyavanich (2018)
Early‐life gut microbiome and egg allergyAllergy, 73
Jurgita Saulytė, Carlos Regueira, A. Montes-Martínez, P. Khudyakov, B. Takkouche (2014)
Active or Passive Exposure to Tobacco Smoking and Allergic Rhinitis, Allergic Dermatitis, and Food Allergy in Adults and Children: A Systematic Review and Meta-AnalysisPLoS Medicine, 11
T. Marrs, K. Logan, J. Craven, S. Radulovic, W. McLean, G. Lack, C. Flohr, M. Perkin, Louise Young, Victoria Offord, Mary DeSousa, Jason Cullen, K. Taylor, Anna Tseng, Bunmi Raji, S. Byrom, Gillian Regis, Charlie Bigwood, Charlotte Stedman, Sharon Tonner, E. Banks, Yasmin Kahnum, R. Babic, B. Stockwell, Erin Thompson, L. Wheatley, Devi Patkunam, K. Richards, Ewa Pietraszewicz, A. Stephens, Asha Sudra, V. Turcanu (2019)
Dog ownership at three months of age is associated with protection against food allergyAllergy, 74
M. Ultsch, Jack Bevers, G. Nakamura, R. Vandlen, R. Kelley, Lawren Wu, C. Eigenbrot (2013)
Structural basis of signaling blockade by anti-IL-13 antibody Lebrikizumab.Journal of molecular biology, 425 8
S. Patil, Johanna Steinbrecher, A. Calatroni, Neal Smith, A. Ma, B. Ruiter, Yamini Virkud, Michael Schneider, W. Shreffler (2019)
Early decrease in basophil sensitivity to Ara h 2 precedes sustained unresponsiveness after peanut oral immunotherapy.The Journal of allergy and clinical immunology
Kai-Ting Shade, B. Platzer, N. Washburn, V. Mani, Y. Bartsch, M. Conroy, J. Pagan, C. Bosques, T. Mempel, E. Fiebiger, R. Anthony (2015)
A single glycan on IgE is indispensable for initiation of anaphylaxisThe Journal of Experimental Medicine, 212
R. Wood (2020)
A 5-Year Summary of Real-Life Dietary Egg Consumption After Completion of a 4-Year Egg Powder Oral Immunotherapy (eOIT) ProtocolPediatrics, 146
(2020)
Designation to Omalizumab for Food Allergies
Sandra Andorf, N. Purington, Divya Kumar, Andrew Long, K. O’Laughlin, S. Sicherer, H. Sampson, A. Cianferoni, T. Whitehorn, D. Petroni, M. Makhija, R. Robison, M. Lierl, S. Logsdon, M. Desai, S. Galli, E. Rael, A. Assa'ad, S. Chinthrajah, J. Pongracic, J. Spergel, J. Tam, S. Tilles, Julie Wang, K. Nadeau (2019)
A Phase 2 Randomized Controlled Multisite Study Using Omalizumab-facilitated Rapid Desensitization to Test Continued vs Discontinued Dosing in Multifood Allergic IndividualsEClinicalMedicine, 7
A. MacGinnitie, R. Rachid, Hana Gragg, S. Little, Paul Lakin, A. Cianferoni, J. Heimall, M. Makhija, R. Robison, R. Chinthrajah, John Lee, Jennifer LeBovidge, T. Dominguez, C. Rooney, Megan Lewis, J. Koss, Elizabeth Burke-Roberts, Kimberly Chin, T. Logvinenko, J. Pongracic, D. Umetsu, J. Spergel, K. Nadeau (2017)
Food , drug , insect sting allergy , and anaphylaxis Omalizumab facilitates rapid oral desensitization for peanut allergy
D. Chu, A. Llop-Guevara, T. Walker, Kristin Flader, S. Goncharova, J. Boudreau, Cheryl LynnMoore, T. In, SusanWaserman, A. Coyle, R. Kolbeck, A. Humbles, M. Jordana
Mechanisms of allergy and clinical immunology IL-33 , but not thymic stromal lymphopoietin or IL-25 , is central to mite and peanut allergic sensitization
R. Wood, Jennifer Kim, R. Lindblad, K. Nadeau, A. Henning, P. Dawson, M. Plaut, H. Sampson (2016)
A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.The Journal of allergy and clinical immunology, 137 4
Chun-Yu Chen, Jee-Boong Lee, Bo Liu, S. Ohta, Pin-Yi Wang, A. Kartashov, Luke Mugge, J. Abonia, A. Barski, K. Izuhara, M. Rothenberg, F. Finkelman, F. Finkelman, S. Hogan, Yui-Hsi Wang (2015)
Induction of Interleukin-9-Producing Mucosal Mast Cells Promotes Susceptibility to IgE-Mediated Experimental Food Allergy.Immunity, 43 4
S. Chinthrajah, S. Cao, Cherie Liu, S. Lyu, S. Sindher, Andrew Long, V. Sampath, D. Petroni, M. Londei, K. Nadeau (2019)
Phase 2a randomized, placebo-controlled study of anti-IL-33 in peanut allergy.JCI insight, 4 22
J. Stockman (2011)
Filaggrin gene defects and risk of developing allergic sensitisation and allergic disorders: systematic review and meta-analysisYearbook of Pediatrics, 2011
O. Burton, S. Logsdon, Joseph Zhou, J. Medina-Tamayo, A. Abdel-Gadir, M. Rivas, K. Koleoglou, T. Chatila, L. Schneider, R. Rachid, D. Umetsu, H. Oettgen (2014)
Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE-mediated hypersensitivity.The Journal of allergy and clinical immunology, 134 6
Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy) -Full Text View -ClinicalTrials.gov
M. Tang, A. Ponsonby, F. Orsini, D. Tey, M. Robinson, E. Su, P. Licciardi, W. Burks, S. Donath (2015)
Administration of a probiotic with peanut oral immunotherapy: A randomized trial.The Journal of allergy and clinical immunology, 135 3
Tomoki Ito, Yu Wang, Omar Duramad, T. Hori, G. Delespesse, N. Watanabe, F. Qin, Z. Yao, W. Cao, Yong‐jun Liu (2005)
TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligandThe Journal of Experimental Medicine, 202
A. Abdel-Gadir, Lynda Schneider, Arianna Casini, L. Charbonnier, S. Little, Timothy Harrington, Dale Umetsu, R. Rachid, T. Chatila (2018)
Oral immunotherapy with omalizumab reverses the Th2 cell‐like programme of regulatory T cells and restores their functionClinical & Experimental Allergy, 48
Our understanding of the immune basis of food allergy has grown rapidly in parallel with the development of new immune‐targeted interventions for the treatment of food allergy. Local tissue factors, including the composition of skin and gastrointestinal microbiota and production of Th2‐inducing cytokines (TSLP, IL‐33, and IL‐25) from barrier sites, have been shown not only to contribute to the development of food allergy, but also to act as effective targets for treatment in mice. Ongoing clinical trials are testing the targeting of these factors in human disease. There is a growing understanding of the contribution of IL‐13 to the induction of high‐affinity IgE and the need for continual T‐cell help in the maintenance of long‐lived IgE. This provides a strong rationale to test biologics targeting both IL‐4 and IL‐13 in the treatment of established food allergy. Various forms of allergen immunotherapy for food allergy have clearly shown that low specific IgE and elevated specific IgG4 are predictive of sustained treatment effect. Treatments that mimic that immune response, for example, lowering IgE, with monoclonal antibodies such as omalizumab, or administering allergen‐specific IgG, are in various stages of investigation. As we gain more opportunities to use immune‐modifying treatments for the treatment of food allergy, studies of the immune and clinical response to those interventions will continue to rapidly advance our understanding of the immune basis of food allergy and tolerance.
Pediatric Allergy and Immunology – Wiley
Published: Oct 1, 2021
Keywords: epicutaneous immunotherapy
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.